Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Developing a method for rapid identification of high-quality disease specific hIPSC lines

  • Post author:
  • Post published:November 15, 2025
  • Post category:

Elucidating how genetic variation contributes to disease susceptibility and drug response requires human Induced Pluripotent Stem Cell (hIPSC) lines from many human patients. Yet, current methods of hIPSC generation are…

Continue ReadingDeveloping a method for rapid identification of high-quality disease specific hIPSC lines

Use of hiPSCs to develop lead compounds for the treatment of genetic diseases

  • Post author:
  • Post published:November 15, 2025
  • Post category:

This study will use Ataxia-Telangiectasia (A-T), an early-onset inherited neurodegenerative disease of children, as a model to study the mechanisms leading to cerebellar neurodegeneration and to develop a drug that…

Continue ReadingUse of hiPSCs to develop lead compounds for the treatment of genetic diseases

Development of small molecule screens for autism using patient-derived iPS cells

  • Post author:
  • Post published:November 15, 2025
  • Post category:

Autism Spectrum Disorders (ASDs) are a heritable group of neuro-developmental disorders characterized by language impairments, difficulties in social integrations, and the presence of stereotyped and repetitive behaviors. There are no…

Continue ReadingDevelopment of small molecule screens for autism using patient-derived iPS cells

Development of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke

  • Post author:
  • Post published:November 15, 2025
  • Post category:

Stroke is the leading cause of adult disability. Most patients survive their initial stroke, but do not recover fully. Because of incomplete recovery, up to 1/3 of stroke patients are…

Continue ReadingDevelopment of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke

Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation

  • Post author:
  • Post published:November 15, 2025
  • Post category:

The objective of this study is to develop a new, optimized technology to obtain a homogenous population of midbrain dopaminergic (mDA) neurons in a culture dish through neuronal differentiation. Dopaminergic…

Continue ReadingSite-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation

Inhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy

  • Post author:
  • Post published:November 15, 2025
  • Post category:

Many neurological disorders are characterized by an imbalance between excitation and inhibition. Our ultimate goal: to develop a cell-based therapy to modulate aberrant brain activity in the treatment of these…

Continue ReadingInhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy

Neural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury

  • Post author:
  • Post published:November 15, 2025
  • Post category:

Traumatic brain injury (TBI) affects 1.4 million Americans a year; 175,000 in California. When the brain is injured, nerve cells near the site of injury die due to the initial…

Continue ReadingNeural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury

Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons

  • Post author:
  • Post published:November 15, 2025
  • Post category:

Injuries to the spinal cord commonly result from motor vehicle accidents, traumatic falls, diving, surfing, skiing, and snowboarding accidents, other forms of sports injuries, as well as from gunshot injuries…

Continue ReadingRepair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons

Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons

  • Post author:
  • Post published:November 15, 2025
  • Post category:

Injuries to the spinal cord commonly result from motor vehicle accidents, traumatic falls, diving, surfing, skiing, and snowboarding accidents, other forms of sports injuries, as well as from gunshot injuries…

Continue ReadingRepair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons

Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell

  • Post author:
  • Post published:November 15, 2025
  • Post category:

Canavan disease is a devastating disease of infants which affects their neural development and leads to mental retardation and early death. It occurs in 1 in 6,400 persons in the…

Continue ReadingDeveloping a therapeutic candidate for Canavan disease using induced pluripotent stem cell
  • Go to the previous page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 34
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us